Yin, Bo <br/><br/>
Inhibition of receptor-interacting protein 3 upregulation and nuclear translocation involved in Necrostatin-1 protection against hippocampal neuronal programmed necrosis induced by ischemia/reperfusion injury.  [electronic resource] 

 -  Brain research  Jun 2015 
 - 63-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-6240 
<br/><br/><label>Standard No.: </label>10.1016/j.brainres.2015.03.024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain Ischemia--drug therapy<br/>CA1 Region, Hippocampal--drug effects<br/>Cathepsin B--metabolism<br/>Cell Death--drug effects<br/>Cytoplasm--drug effects<br/>Dose-Response Relationship, Drug<br/>Imidazoles--pharmacology<br/>Indoles--pharmacology<br/>Lysosomes--drug effects<br/>Male<br/>Necrosis--drug therapy<br/>Neurons--drug effects<br/>Neuroprotective Agents--pharmacology<br/>Poly (ADP-Ribose) Polymerase-1<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>Protein Serine-Threonine Kinases--metabolism<br/>Rats, Sprague-Dawley<br/>Receptor-Interacting Protein Serine-Threonine Kinases--metabolism<br/>Reperfusion Injury--drug therapy<br/>Up-Regulation--drug effects